Actelis Networks, Inc. (ASNS) earnings
ASNS earnings moved a median of -0.08% by the close. Quarterly and annual ASNS reports and results, each read against the price at its own news timestamp. Back to the ASNS overview →
22 measured ASNS earnings events.
Where these ASNS earnings landedvs 22 measured ASNS earnings reactions
| Middle 50% of ASNS earnings reactions | -2.59% to +1.45% |
|---|---|
| Median reaction (to close) | -0.08% |
| Measured reactions | 22 |
Point-in-time · zero look-ahead
Half of the 22 ASNS earnings events with a measured close landed between -2.59% and +1.45%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Actelis Networks Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | -9.89% | -5.51% | |
| Form 10-Q ACTELIS NETWORKS INC For: Jun 30 | SEC filing · Form 10-Q | -9.89% | -5.51% | |
| Actelis Networks Reports First Quarter 2026 Financial Results With 33% Year-Over-Year Revenue Growth | Press release | +7.99% | -1.60% | |
| Form 10-Q ACTELIS NETWORKS INC For: Mar 31 | SEC filing · Form 10-Q | +7.99% | -1.60% | |
| Form 10-K ACTELIS NETWORKS INC For: Dec 31 | SEC filing · Form 10-K | -3.42% | -1.39% | |
| Actelis Networks Reports Third Quarter 2025 Financial Results and Operational Update | Press release | +1.08% | +0.61% | |
| Form 10-Q ACTELIS NETWORKS INC For: Sep 30 | SEC filing · Form 10-Q | +1.08% | +0.61% | |
| Actelis Networks Reports Second Quarter 2025 Financial Results and Operational Update | Press release | -0.89% | -9.80% | |
| Form 10-Q ACTELIS NETWORKS INC For: Jun 30 | SEC filing · Form 10-Q | -0.89% | -9.80% | |
| Actelis Networks Reports First Quarter 2025 Financial Results With Stable Revenues Alongside Increased Global Partners Coverage And Operational Efficiency | Press release | -5.87% | +1.45% | |
| Form 10-Q ACTELIS NETWORKS INC For: Mar 31 | SEC filing · Form 10-Q | -5.87% | +1.45% | |
| Actelis Networks to Report First Quarter 2025 Results on May 13, 2025 | Press release | +0.00% | -0.17% | |
| Form 10-K ACTELIS NETWORKS INC For: Dec 31 | SEC filing · Form 10-K | -3.51% | -9.65% | |
| Actelis Networks Reports Q3 2024 Results: 200% Quarterly Revenue Growth; 46% Year-to-Date Growth Reaching $6.7 Million | Press release | -1.40% | -0.75% | |
| Form 10-Q ACTELIS NETWORKS INC For: Sep 30 | SEC filing · Form 10-Q | +0.73% | -2.92% | |
| Actelis Networks Reports Q2 2024 Results: 372% Sequential Revenue Growth, 81% Year-Over-Year Increase, and Positive EBITDA | Press release | +1.51% | +4.54% | |
| Form 10-Q ACTELIS NETWORKS INC For: Jun 30 | SEC filing · Form 10-Q | +1.51% | +4.54% | |
| Actelis Networks Reports Fiscal First Quarter 2024 | Press release | +2.42% | +3.06% | |
| Form 10-Q ACTELIS NETWORKS INC For: Mar 31 | SEC filing · Form 10-Q | +2.42% | +3.06% | |
| Form 10-K ACTELIS NETWORKS INC For: Dec 31 | SEC filing · Form 10-K | +0.74% | +2.09% | |
| Actelis Networks Reports Third Quarter 2023 | Press release | +0.00% | +0.00% | |
| Form 10-Q ACTELIS NETWORKS INC For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.00% |
Keep exploring
More ASNS: analyst actions → · SEC filings → · ASNS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Protagonist Therapeutics, Inc. (PTGX) | 335 | -0.24% | 43% |
| MYOS RENS TECH INC COMMON (MYOS) | 334 | 0.00% | 43% |
| Collegium Pharmaceutical, Inc. (COLL) | 330 | +0.15% | 56% |
| BG MEDICINE INC (BGMD) | 329 | 0.00% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.